AA,Jamaica government says Alcoa to pull out of country KINGSTON, June 13 The Jamaican government said on Friday that mining company Alcoa will pull out of Jamaica within two years. 
AGN,Valeant senior official leaves amid Allergan takeover battle June 14 An executive vice-president of Valeant Pharmaceuticals International Inc will leave the company, even as the Canadian drugmaker fends off criticism about management turnover from its takeover target Allergan Inc . 
AMZN,Italy's Prandelli happy with pitch, wary of different England MANAUS Brazil Italy have the know-how to beat a much improved England side boasting plenty of attacking talent on a good pitch that should produce a spectacular clash in the Amazon city of Manaus, coach Cesare Prandelli said on Friday. 
BLK,BlackRock says CS guilty plea has no impact on relationship -paper ZURICH, June 14 BlackRock Inc. said Credit Suisse's guilty plea in a U.S. tax evasion case does not affect its business relationship with the Swiss bank, the chief executive of the world's biggest asset manager told a Swiss newspaper. 
MDT,Sanofi and Medtronic team up on diabetes drug-device combinationSanofi and Medtronic team up on diabetes drug-device combinationMedtronic, Covidien in advanced talks to combine -WSJMedtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   June 14 Medical-device maker Medtronic Inc  and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.     Medtronic, Covidien in advanced talks to combine -WSJMedtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   June 14 Medical-device maker Medtronic Inc  and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.Medtronic, Covidien in advanced talks to combine -WSJMedtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   June 14 Medical-device maker Medtronic Inc  and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.      Sanofi and Medtronic team up on diabetes drug-device combinationMedtronic, Covidien in advanced talks to combine -WSJMedtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   June 14 Medical-device maker Medtronic Inc  and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.     Medtronic, Covidien in advanced talks to combine -WSJMedtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   June 14 Medical-device maker Medtronic Inc  and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.Medtronic, Covidien in advanced talks to combine -WSJMedtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   June 14 Medical-device maker Medtronic Inc  and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.     PARIS French drugmaker Sanofi said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.Sanofi and Medtronic team up on diabetes drug-device combinationMedtronic, Covidien in advanced talks to combine -WSJMedtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   June 14 Medical-device maker Medtronic Inc  and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.     Medtronic, Covidien in advanced talks to combine -WSJMedtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   June 14 Medical-device maker Medtronic Inc  and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.Medtronic, Covidien in advanced talks to combine -WSJMedtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.    Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   June 14 Medical-device maker Medtronic Inc  and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.Medtronic in talks to combine with Covidien in $45 bln deal -sourceUPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.   UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  June 14 U.S. medical device maker Medtronic Inc  is in advanced talks to merge with rival Covidien Plc  in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.UPDATE 3-Sanofi and Medtronic team up on diabetes drug-device combinationUPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.  UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday. PARIS, June 14 French drugmaker Sanofi  said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes.UPDATE 4-Medtronic nears $45 billion-plus deal for Covidien -sources NEW YORK/CHICAGO, June 14 U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.      
